Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mirum Pharmaceuticals (MIRM) Other Non Operating Income: 2019-2024

Historic Other Non Operating Income for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Dec 2024 value amounting to $1.2 million.

  • Mirum Pharmaceuticals' Other Non Operating Income rose 136.34% to $395,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 22.40%. This contributed to the annual value of $1.2 million for FY2024, which is 102.47% up from last year.
  • As of FY2024, Mirum Pharmaceuticals' Other Non Operating Income stood at $1.2 million, which was up 102.47% from -$49.1 million recorded in FY2023.
  • Mirum Pharmaceuticals' Other Non Operating Income's 5-year high stood at $1.2 million during FY2024, with a 5-year trough of -$49.1 million in FY2023.
  • Moreover, its 3-year median value for Other Non Operating Income was $365,000 (2022), whereas its average is -$15.8 million.
  • In the last 5 years, Mirum Pharmaceuticals' Other Non Operating Income skyrocketed by 162.71% in 2022 and then tumbled by 13,545.48% in 2023.
  • Over the past 5 years, Mirum Pharmaceuticals' Other Non Operating Income (Yearly) stood at -$192,000 in 2020, then crashed by 203.12% to -$582,000 in 2021, then surged by 162.71% to $365,000 in 2022, then tumbled by 13,545.48% to -$49.1 million in 2023, then skyrocketed by 102.47% to $1.2 million in 2024.